Abstract

The American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG-AMP) system for variant classification is score based with five classes: benign, likely benign, variant of unknown significance (VUS), likely pathogenic, and pathogenic. Here, we present a variant classification model that can be an add-on or alternative to ACMG classification: A stepwise system that can classify any type of genetic variant (e.g., hypomorphic alleles, imprinted alleles, copy number variants, runs of homozygosity, enhancer variants, and variants related to traits). We call it the ABC system because classification is first functional (A), then clinical (B), and optionally a standard comment that fits the clinical question is selected (C). Both steps A and B have 1–5 grading when knowledge is sufficient, if not, class “zero” is assigned. Functional grading (A) only concerns biological consequences with the stages normal function (1), likely normal function (2), hypothetical functional effect (3), likely functional effect (4), and proven functional effect (5). Clinical grading (B) is genotype–phenotype focused with the stages “right type of gene” (1), risk factor (2), and pathogenic (3–5, depending on penetrance). Both grades are listed for each variant and combined to generate a joint class ranging from A to F. Importantly, the A–F classes are linked to standard comments, reflecting laboratory or national policy. In step A, the VUS class is split into class 0 (true unknown) and class 3 (hypothetical functional effect based on molecular predictions or de novo occurrence), providing a rationale for variant-of-interest reporting when the clinical picture could fit the finding. The system gives clinicians a better guide to variant significance.

Highlights

  • A comparison of large US laboratories that used the American College of Medical Genetics and Genomics (ACMG) system showed that concordance in general is good (~90%) [4], especially for high-penetrant variants [5]

  • A good system for variant classification is essential for mainstreaming precision medicine

  • The prevailing system is developed by ACMG and Association for Molecular Pathology (AMP)

Read more

Summary

Introduction

Broad genomic testing, using massive parallel sequencing and high-resolution arrays, is the fundamental of nextgeneration clinical genetics and precision medicine. This development has unleashed an urgent need to share and evaluate genetic variants. For clinical purposes, sharing disease-associated variants is important, e.g., in databases like ClinVar All types of genetic variants should be evaluated in a reproducible and transparent way that makes inter-laboratory interpretations of the same variant as informative as possible. This can be challenging and discrepancies may occur [1,2,3]. Gene- or disease-specific classification systems, which are designed to help, may, further increase the classification complexity [6,7,8,9,10,11,12]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call